Abstract
The tumours of the disseminated/diffuse neuroendocrine cell system are a group of neoplasms sharing uniformly appearing cells which differ from each other in their biology, prognosis and genetics. In the lung they are called carcinoid and small/large-cell neuroendocrine carcinomas. In the gastroenteropancreatic compartment they are classified as well-differentiated neuroendocrine tumours or carcinomas and poorly differentiated neuroendocrine carcinomas. Depending on their localization these neoplasms reveal distinct phenotypes with respect to pathology, immunohistochemistry, and hormonal syndromes. Their clinical behaviour - ranging from benign and low-grade to high-grade malignancy - can be predicted on the basis of clinicopathological criteria. Currently extensive work is being performed to unravel the genetic background.
Originalsprache | Englisch |
---|---|
Seiten (von - bis) | 15-31 |
Seitenumfang | 17 |
Fachzeitschrift | Best Practice and Research: Clinical Endocrinology and Metabolism |
Jahrgang | 21 |
Ausgabenummer | 1 |
DOIs | |
Publikationsstatus | Veröffentlicht - März 2007 |
Extern publiziert | Ja |